Definitive Healthcare (DH) EBITDA (2020 - 2026)

Definitive Healthcare (DH) has reported EBITDA for 7 consecutive years, with -$6.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA fell 61.82% year-over-year to -$6.7 million; the trailing twelve-month figure through Jun 2026 stood at -$243.4 million (up 52.64% YoY), and the FY2025 full-year result was -$224.3 million, up 68.45% from the prior year.
• EBITDA advanced to -$6.7 million in Q2 2026 per DH's latest filing, from -$201.3 million in the prior quarter.
• Across five years, EBITDA topped out at -$4.2 million in Q2 2025 and bottomed at -$369.6 million in Q2 2024.
• Historically, EBITDA has averaged -$84.3 million across 5 years, with a median of -$12.2 million in 2023.
• The sharpest annual moves came in 2024 and 2025: EBITDA tumbled 2962.22% in 2024, then jumped 98.87% in 2025.
• Over 5 years, EBITDA stood at -$10.5 million in 2022, then advanced by 4.34% to -$10.1 million in 2023, then tumbled by 887.73% to -$99.6 million in 2024, then surged by 73.26% to -$26.6 million in 2025, then soared by 74.66% to -$6.7 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered -$6.7 million, -$201.3 million, and -$26.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.